InvestorsHub Logo
Followers 64
Posts 7223
Boards Moderated 0
Alias Born 05/28/2004

Re: None

Monday, 05/13/2019 10:52:05 AM

Monday, May 13, 2019 10:52:05 AM

Post# of 111073
What is so cool is that our favorite ticker, CELZ, is working on StemSpine another regenerative stem cell treatment. From a medical point of view, I can barely wait until it’s available. And from an investment standpoint, well, it’s another revenue stream coming sooner than later.

"StemSpineTM is expected to launch in late 2019. We feel it is in the best interest of the company to dedicate much of our resources to continue to build those brands and our cash flow before commercializing StemSpine."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News